Details for New Drug Application (NDA): 204374
✉ Email this page to a colleague
NDA 204374 describes SOLIFENACIN SUCCINATE, which is a drug marketed by Accord Hlthcare, Ajanta Pharma Ltd, Alembic, Alkem Labs Ltd, Amneal Pharms Co, Annora Pharma, Aurobindo Pharma, Bostal, Breckenridge, Chartwell Rx, Cipla, Glenmark Speclt, Jubilant Generics, Lannett Co Inc, Macleods Pharms, MSN, Novitium Pharma, Qilu, Rising, Sciegen Pharms, Sunshine, Teva Pharms Usa, Torrent, Unichem, Watson Labs Inc, and Zydus Pharms, and is included in twenty-six NDAs. It is available from twenty suppliers. Additional details are available on the SOLIFENACIN SUCCINATE profile page.
The generic ingredient in SOLIFENACIN SUCCINATE is solifenacin succinate. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the solifenacin succinate profile page.
The generic ingredient in SOLIFENACIN SUCCINATE is solifenacin succinate. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the solifenacin succinate profile page.
Summary for 204374
| Tradename: | SOLIFENACIN SUCCINATE |
| Applicant: | Macleods Pharms |
| Ingredient: | solifenacin succinate |
| Patents: | 0 |
Pharmacology for NDA: 204374
| Mechanism of Action | Cholinergic Muscarinic Antagonists |
Medical Subject Heading (MeSH) Categories for 204374
Suppliers and Packaging for NDA: 204374
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 204374 | ANDA | Macleods Pharmaceuticals Limited | 33342-148 | 33342-148-07 | 30 TABLET, COATED in 1 CONTAINER (33342-148-07) |
| SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 204374 | ANDA | Macleods Pharmaceuticals Limited | 33342-148 | 33342-148-10 | 90 TABLET, COATED in 1 CONTAINER (33342-148-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Feb 20, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Feb 20, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
